However, it demonstrated that IL-17 concentration showed a positive correlation with the level of IL-6 (r = 0.5415, P = 0.0009) (Figure 5(a)) in ND AML patients, but did not reach statistical correlation in CR, relapsed-refractory, or control groups. The gene discussed is IL17A; the disease is acute myeloid leukemia.